Candida epiglottitis in immunocompromised patients

T. J. Walsh, W. C. Gray

Research output: Contribution to journalArticle

Abstract

Candida seldom has been reported to be a cause of epiglottitis. The clinical manifestations and management of three patients with Candida epiglottitis complicating their neoplastic disease are described. All patients were granulocytopenic. Candida epiglottitis occurred either as a localized infection, as a source of Candida bronchopneumonia, or as a manifestation of disseminated infection. Candida epiglottitis may be under-diagnosed and should be considered, especially in immunocompromised patients with symptoms of refractory pharyngitis. Treatment of Candida epiglottitis with intravenous amphotericin B is warranted in patients with sustained granulocytopenia. Prompt endotracheal intubation is indicated if the airway patency cannot be maintained.

Original languageEnglish (US)
Pages (from-to)482-485
Number of pages4
JournalChest
Volume91
Issue number4
StatePublished - 1987

Fingerprint

Epiglottitis
Immunocompromised Host
Candida
Bronchopneumonia
Agranulocytosis
Intratracheal Intubation
Pharyngitis
Amphotericin B
Infection

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Walsh, T. J., & Gray, W. C. (1987). Candida epiglottitis in immunocompromised patients. Chest, 91(4), 482-485.

Candida epiglottitis in immunocompromised patients. / Walsh, T. J.; Gray, W. C.

In: Chest, Vol. 91, No. 4, 1987, p. 482-485.

Research output: Contribution to journalArticle

Walsh, TJ & Gray, WC 1987, 'Candida epiglottitis in immunocompromised patients', Chest, vol. 91, no. 4, pp. 482-485.
Walsh TJ, Gray WC. Candida epiglottitis in immunocompromised patients. Chest. 1987;91(4):482-485.
Walsh, T. J. ; Gray, W. C. / Candida epiglottitis in immunocompromised patients. In: Chest. 1987 ; Vol. 91, No. 4. pp. 482-485.
@article{9fa01fd8d3b040b98ff6ca94a22eb116,
title = "Candida epiglottitis in immunocompromised patients",
abstract = "Candida seldom has been reported to be a cause of epiglottitis. The clinical manifestations and management of three patients with Candida epiglottitis complicating their neoplastic disease are described. All patients were granulocytopenic. Candida epiglottitis occurred either as a localized infection, as a source of Candida bronchopneumonia, or as a manifestation of disseminated infection. Candida epiglottitis may be under-diagnosed and should be considered, especially in immunocompromised patients with symptoms of refractory pharyngitis. Treatment of Candida epiglottitis with intravenous amphotericin B is warranted in patients with sustained granulocytopenia. Prompt endotracheal intubation is indicated if the airway patency cannot be maintained.",
author = "Walsh, {T. J.} and Gray, {W. C.}",
year = "1987",
language = "English (US)",
volume = "91",
pages = "482--485",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Candida epiglottitis in immunocompromised patients

AU - Walsh, T. J.

AU - Gray, W. C.

PY - 1987

Y1 - 1987

N2 - Candida seldom has been reported to be a cause of epiglottitis. The clinical manifestations and management of three patients with Candida epiglottitis complicating their neoplastic disease are described. All patients were granulocytopenic. Candida epiglottitis occurred either as a localized infection, as a source of Candida bronchopneumonia, or as a manifestation of disseminated infection. Candida epiglottitis may be under-diagnosed and should be considered, especially in immunocompromised patients with symptoms of refractory pharyngitis. Treatment of Candida epiglottitis with intravenous amphotericin B is warranted in patients with sustained granulocytopenia. Prompt endotracheal intubation is indicated if the airway patency cannot be maintained.

AB - Candida seldom has been reported to be a cause of epiglottitis. The clinical manifestations and management of three patients with Candida epiglottitis complicating their neoplastic disease are described. All patients were granulocytopenic. Candida epiglottitis occurred either as a localized infection, as a source of Candida bronchopneumonia, or as a manifestation of disseminated infection. Candida epiglottitis may be under-diagnosed and should be considered, especially in immunocompromised patients with symptoms of refractory pharyngitis. Treatment of Candida epiglottitis with intravenous amphotericin B is warranted in patients with sustained granulocytopenia. Prompt endotracheal intubation is indicated if the airway patency cannot be maintained.

UR - http://www.scopus.com/inward/record.url?scp=0023092094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023092094&partnerID=8YFLogxK

M3 - Article

C2 - 3829737

AN - SCOPUS:0023092094

VL - 91

SP - 482

EP - 485

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -